PHARMATHENE, INC 4
4 · PHARMATHENE, INC · Filed Dec 10, 2014
Insider Transaction Report
Form 4
CHANG LINDA L
SVP & CFO
Transactions
- Award
Stock options (right to buy)
2014-12-08+186,207→ 186,207 totalExercise: $1.71Exp: 2024-12-08→ Common Stock (186,207 underlying)
Footnotes (2)
- [F1]The options vest over a 4-year period with 25% each vesting on the first, second, third and fourth anniversaries of the grant date.
- [F2]On December 8, 2014, the date the stock options were granted, the NYSE MKT closing price for the Issuer's common stock was $1.71 per share.